Jane Street’s Verastem VSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$95.1K Buy
+24,900
New +$120K ﹤0.01% 10624
2026
Q1
Sell
-25,600
Closed -$198K 13118
2025
Q4
$198K Buy
25,600
+700
+3% +$6.24K ﹤0.01% 9730
2025
Q3
$220K Sell
24,900
-6,100
-20% -$45.4K ﹤0.01% 9492
2025
Q2
$129K Buy
+31,000
New +$194K ﹤0.01% 8844
2022
Q1
Sell
-1,500
Closed -$37K 11091
2021
Q4
$37K Sell
1,500
-67
-4% -$2.12K ﹤0.01% 9640
2021
Q3
$58K Buy
+1,567
New +$57.6K ﹤0.01% 9502

Other funds holding VSTM

Jane Street's VSTM Position: Q2 2026 in Review

Jane Street sold out of Verastem (VSTM) in Q2 2026, closing a stake of 570,618 shares — an estimated $2.76M sold.

Jane Street first reported a position in VSTM in Q3 2014 and held it in 20 quarters. The position peaked at $3.02M in Q1 2026. 156 funds tracked by Wall St. Rank hold VSTM as of Q2 2026.

  • Jane Street reported no remaining Verastem position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 570,618 Verastem shares in Q2 2026, an estimated $2.76M.
  • Jane Street first reported a position in Verastem in Q3 2014 and held it in 20 quarters.
  • Jane Street's Verastem position peaked at $3.02M in Q1 2026.
  • 156 funds tracked by Wall St. Rank held Verastem as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.